心血管疾病药物的哺乳安全性
Cristina Nunez-Pellot1, Allison Akers2, Sarah Običan2
1Division of Cardiovascular Sciences, Department of Medicine, University of South Florida Morsani College of Medicine, Tampa, FL, USA.
概括
哺乳是有益的,但患有心血管疾病的母亲面临着挑战. 本综述评估了哺乳期心脏药物安全性,以支持明智的决策和提高母乳养率.
科学领域:
- 心脏病学 心脏病学
- 新生儿医学 新生儿医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 哺乳提供了显著的母婴健康益处.
- 以前患有心血管疾病 (CVD) 的母亲的母乳养率较低.
- 在哺乳期对心脏药物安全性的担忧可能会导致早期停产.
研究的目的:
- 对患有心血管疾病的母亲使用常见心脏药物的哺乳期安全性进行审查.
- 为了指导临床决策,关于母乳养与心血管疾病.
主要方法:
- 对心脏药物和母乳养现有证据的文献综述.
- 药物动力学原理的应用,以评估药物转移到母乳中的情况.
主要成果:
- 对于一些心脏药物在哺乳期的安全性数据有限.
- 药物动力学数据可以为药物暴露的风险评估提供信息.
- 提供者对心脏药物安全性的知识至关重要.
结论:
- 对于患有心血管疾病的哺乳母亲来说,共享决策至关重要.
- 改善有关心脏药物和哺乳安全性的提供者教育可以提高母乳养的结果.
- 对于全面的安全配置文件,还需要进一步的研究.
相关概念视频
Adrenergic Antagonists: ɑ and β-Receptor Blockers
420
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
420
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.3K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.3K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
791
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
791
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
718
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
718
Factors Affecting Drug Response: Overview
1.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.1K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.1K


